By: Christopher P. Molineaux
President
Pennsylvania Bio

As we all know, our industry operates in a highly-regulated and cash-intense environment where it takes 12 to 15 years and between $800 million to $1.2 billion to bring a product to market. 

For some companies, not getting that next infusion of cash could mean the end of years of research and the end of the hope for that potential treatment for Alzheimer’s disease, diabetes, breast cancer, and countless other debilitating diseases.

Creative and Changing Deal Structures
August 19, 2010
The Desmond Great Valley Hotel

October 27-28, 2010
Pennsylvania Convention Center
Philadelphia, PA

Schwartz Led Effort to Include Program in the Health Care Reform Law

September 15, 2010
The Kimmel Center | Philadelphia

Nominations Due Monday, August 2nd

Pennsylvania Bio Members Now Have Access to LinkedIn Group

QR Pharma, Inc., a developer of novel drugs to treat Alzheimer’s disease (AD), has presented a poster on positive clinical data from its recent mechanism of action study in mild cognitive impaired (MCI) patients at the International Congress on Alzheimer’s Disease (ICAD 2010).

Integral Molecular, Inc. has announced the issuance of a key patent covering its technology for deriving high concentrations of membrane proteins.

Study published in The Journal of Molecular Diagnostics

This new patent is Progenra’s first in a series of novel ubiquitin proteasome pathway patents giving them exclusive rights to HTS technology that facilitates discovery of inhibitors or activators of any of vast numbers of human, viral, fungal and bacterial deubiquitylating enzymes.

Endo Pharmaceuticals has submitted a complete response to the U.S. Food and Drug Administration (FDA) following the company's receipt of a Complete Response letter in October 2009 related to the New Drug Application (NDA) submission for FORTESTA(TM) (testosterone) 2% gel.

Saladax Biomedical, Inc. has announced that it has achieved ISO 13485:2003 certification for the design, manufacture and distribution of in vitro diagnostic medical devices in the area of clinical chemistry.

Pennsylvania Bio Congratulates the Hospital of the University of Pennsylvania and the University of Pittsburgh Medical Center

Orthovita, Inc., an orthobiologics and biosurgery company, has reported that the U.S. Food and Drug Administration (FDA) approved Orthovita’s PMA supplement for a new collagen processing facility in Malvern, Pennsylvania.

Percorso Life Sciences (PLS) announces an agreement to represent Generation Biotech (GB) to commercialize its SNPSeq^TM product portfolio and provide strategic business development.

Trevena, Inc., has announced that it has completed a $35 million Series B financing.

Company to Develop Lead Product for Rosacea and Other Topical Agents for the Treatment of Skin Disorders

Program Targets 11beta-HSD-1 for the Treatment of Diabetes and Other Metabolic Syndrome Disorders

NCCN recently received two individual $2 million research grants from GlaxoSmithKline to evaluate the effectiveness of ofatumumab in hematologic malignancies and pazopanib in the treatment of solid tumors. Investigators from NCCN Member Institutions are eligible to apply for the research funding.

Up to $4 million available over five years

Representative Scott Petri
178th Legislative District

Economics will play a big role in Pennsylvania’s ability to sustain a thriving bioscience industry and the family sustaining jobs it creates and supports.

Provides Update on FMAP Extension

After 10 years of serving the people of the 45th District, state Senator Sean Logan (D-Allegheny/Westmoreland) plans to depart the Pennsylvania Senate and assume the role as Vice President of Community Relations for the University of Pittsburgh Medical Center (UPMC).

The Children's Hospital of Philadelphia has a long and distinguished tradition of research that has spanned more than 80 years and positioned the Hospital as a world-renowned pediatric research center. The many research breakthroughs at Children's Hospital have improved the lives of countless children not only in the Philadelphia region, but throughout the world.

The world-class Microscopy School at Lehigh University has taught more than 5,000 students on state-of-the-art instruments since 1970.

Penn State Hershey offers three new special e-mail newsletters, customized to health care needs. Beginning this July, Health eNews, Pregnancy, and New Parent e-newsletters give subscribers the opportunity to receive regular health care information based on the interests each subscriber selects.